People | June 14, 2024
AxoSim appoints Alif Saleh as CEO
Co-founder and previous CEO Lowry Curley becomes Chief Scientific Officer
Co-founder and previous CEO Lowry Curley becomes Chief Scientific Officer
DurA Cycle is designed for large-scale commercial manufacturing of monoclonal antibodies,
Ashkenazi will continue to serve at full capacity in her role and as a member of Lilly's Executive Committee through July 2024
Seymour is recognized as one of the foremost quality leaders in the pharmaceutical industry
Seymour is recognized as one of the foremost quality leaders in the pharmaceutical industry
Greg was also central to the planning, design, and construction of this facility
The new facility will accelerate the biotech and pharmaceutical industry's development by manufacturing vaccines, cell and gene therapies, and protein-based therapies
Acquisition includes Restoret, a novel late-phase candidate for diabetic macular edema and neovascular age-related macular degeneration
Largest investment in active pharmaceutical ingredient manufacturing of synthetic medicines in U.S. history
The acquisition is immediately accretive and creates a compelling, single-stop, multi-continent partner for biopharma companies
Subscribe To Our Newsletter & Stay Updated
